{
  "generated": "2025-11-06T07:17:06.875875+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/physiological/chondroitin-musc-gen-0716/musculoskeletal/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "MUSC-GEN-0716_01",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "musculoskeletal_journal",
      "outcome": "muscle_mass",
      "population": "Adults with muscle mass concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/chondroitin-musc-gen-0716-01",
      "url": "https://doi.org/10.1234/chondroitin-musc-gen-0716-01",
      "citation": "MUSC-GEN-0716_01 (2016); Journal: musculoskeletal_journal; Design: randomized controlled trial; Population: Adults with muscle mass concerns; Outcome: muscle_mass; DOI: 10.1234/chondroitin-musc-gen-0716-01; Adverse Events: None reported."
    },
    {
      "study_id": "MUSC-GEN-0716_02",
      "year": 2017,
      "design": "randomized controlled trial",
      "journal": "musculoskeletal_journal",
      "outcome": "muscle_mass",
      "population": "Adults with muscle mass concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/chondroitin-musc-gen-0716-02",
      "url": "https://doi.org/10.1234/chondroitin-musc-gen-0716-02",
      "citation": "MUSC-GEN-0716_02 (2017); Journal: musculoskeletal_journal; Design: randomized controlled trial; Population: Adults with muscle mass concerns; Outcome: muscle_mass; DOI: 10.1234/chondroitin-musc-gen-0716-02; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "MUSC-GEN-0716_03",
      "year": 2018,
      "design": "randomized controlled trial",
      "journal": "musculoskeletal_journal",
      "outcome": "muscle_mass",
      "population": "Adults with muscle mass concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/chondroitin-musc-gen-0716-03",
      "url": "https://doi.org/10.1234/chondroitin-musc-gen-0716-03",
      "citation": "MUSC-GEN-0716_03 (2018); Journal: musculoskeletal_journal; Design: randomized controlled trial; Population: Adults with muscle mass concerns; Outcome: muscle_mass; DOI: 10.1234/chondroitin-musc-gen-0716-03; Adverse Events: Mild GI discomfort."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/chondroitin-musc-gen-0716-01",
      "study_ids": [
        "MUSC-GEN-0716_01"
      ],
      "primary_study_id": "MUSC-GEN-0716_01",
      "url": "https://doi.org/10.1234/chondroitin-musc-gen-0716-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/chondroitin-musc-gen-0716-02",
      "study_ids": [
        "MUSC-GEN-0716_02"
      ],
      "primary_study_id": "MUSC-GEN-0716_02",
      "url": "https://doi.org/10.1234/chondroitin-musc-gen-0716-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/chondroitin-musc-gen-0716-03",
      "study_ids": [
        "MUSC-GEN-0716_03"
      ],
      "primary_study_id": "MUSC-GEN-0716_03",
      "url": "https://doi.org/10.1234/chondroitin-musc-gen-0716-03"
    }
  ],
  "manifest_hash": "sha256:97dd49535c7f92e5f30009dc56b96eea0e439cffd910ff3c363909064b65674f"
}
